1,265
Views
5
CrossRef citations to date
0
Altmetric
Vaccination

A cost-effectiveness analysis of revaccination and catch-up strategies with the 23-valent pneumococcal polysaccharide vaccine (PPV23) in older adults in Japan

, , , &
Pages 687-697 | Received 21 Mar 2018, Accepted 09 Apr 2018, Published online: 03 May 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Atsushi Tajima, Machiko Abe, Jessica Weaver & Min Huang. (2023) Cost-effectiveness analysis of pediatric immunization program with 15-valent pneumococcal conjugate vaccine in Japan. Journal of Medical Economics 26:1, pages 1034-1046.
Read now

Articles from other publishers (4)

Lois A. Privor-Dumm, Gregory A. Poland, Jane Barratt, David N. Durrheim, Maria Deloria Knoll, Prarthana Vasudevan, Mark Jit, Pablo E. Bonvehí & Paolo Bonanni. (2021) A global agenda for older adult immunization in the COVID-19 era: A roadmap for action. Vaccine 39:37, pages 5240-5250.
Crossref
Xiaodong Sun, Yuekun Tang, Xiaoying Ma, Xiang Guo, Zhuoying Huang, Jia Ren, Jing Qiu, Hongli Jiang & Yihan Lu. (2021) Cost-Effectiveness Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine Program for the Elderly Aged 60 Years or Older in Shanghai, China. Frontiers in Public Health 9.
Crossref
Bruce Y. Lee, Sarah M. Bartsch, Marie C. Ferguson, Patrick T. Wedlock, Kelly J. O’Shea, Sheryl S. Siegmund, Sarah N. Cox & James A. McKinnell. (2021) The value of decreasing the duration of the infectious period of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. PLOS Computational Biology 17:1, pages e1008470.
Crossref
Yoshitaka Murakami, Shinichi Kanazu, Tanaz Petigara, Mari Saito Oba, Yuji Nishiwaki & Akira Watanabe. (2019) Factors associated with PPSV23 coverage among older adults in Japan: a nationwide community-based survey. BMJ Open 9:7, pages e030197.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.